EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation

NCT02561897 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Did not meet enrolment target for phase 1

Conditions

Atrial Fibrillation

Interventions

DRUG: Edoxaban
DRUG: Warfarin

Sponsor

Electrophysiology Research Foundation

Collaborators

[object Object]